Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00610415 · ClinicalTrials.gov registry record
Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study
A clinical trial of Head and Neck Cancer and Head and Neck Cancers, sponsored by Stanford University.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT00610415 is a study of Head and Neck Cancer and Head and Neck Cancers that has completed, run by Stanford University. The registered enrollment target is 40 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00610415, a study of Head and Neck Cancer and Head and Neck Cancers, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
To see if a limited sampling of tumor tissue from human subjects is a feasible way to gather adequate tissue for cancer stem cell quantification.
Conditions Studied
Interventions
- PROCEDURE tumor biopsy
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00610415
The ClinicalTrials.gov registry entry for NCT00610415 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (85% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which tumor biopsy is the first listed.
NCT00610415 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00610415 about?
NCT00610415 is a clinical study titled "Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study". To see if a limited sampling of tumor tissue from human subjects is a feasible way to gather adequate tissue for cancer stem cell quantification.
What is the current status of trial NCT00610415?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2007-12.
What conditions does trial NCT00610415 study?
This clinical trial studies the following conditions: Head and Neck Cancer, Head and Neck Cancers.
What interventions are being tested in trial NCT00610415?
The interventions under investigation include: tumor biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00610415?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00610415 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
3D Specimen Maps for RT Planning
RECRUITING
-
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
RECRUITING · Phase 1
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
RECRUITING · NA
-
RAPA-201 Therapy of Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.